Abstract
Immunology & Cell BiologyVolume 96, Issue 2 p. 236-236 ErratumFree Access Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells, by Varun Sasidharan Nair and Eyad Elkord (Erratum) This article corrects the following: Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells Varun Sasidharan Nair, Eyad Elkord, Volume 96Issue 1Immunology and Cell Biology pages: 21-33 First Published online: November 17, 2017 First published: 23 February 2018 https://doi.org/10.1111/imcb.12012Citations: 1AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat In Sasidharan Nair and Elkord,1 Reference 116 was incorrectly inserted as Reference 11 in the print edition of the January 2018 issue, causing numbering errors in all references. This error has been corrected in the online version of the article, available at the following link: http://onlinelibrary.wiley.com/doi/10.1111/imcb.1003/full The publisher apologizes for the error. Reference 1Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells. Immunol Cell Biol 2018; 96: 21– 33. Citing Literature Volume96, Issue2February 2018Pages 236-236 Journal of the Australian and New Zealand Society for Immunology ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
